Early Hepatic Artery Thrombosis After Pediatric Living Donor Liver Transplantation.


Journal

Transplantation proceedings
ISSN: 1873-2623
Titre abrégé: Transplant Proc
Pays: United States
ID NLM: 0243532

Informations de publication

Date de publication:
May 2019
Historique:
received: 23 12 2018
accepted: 21 01 2019
entrez: 19 5 2019
pubmed: 19 5 2019
medline: 17 7 2019
Statut: ppublish

Résumé

Hepatic artery thrombosis is one of the major complications affecting patient and graft survival after liver transplantation. In this study, we analyzed the factors affecting the development of early hepatic artery thrombosis (eHAT) and its outcomes in pediatric liver transplantation. A total of 175 pediatric patients underwent living donor liver transplantation between January 2013 and November 2018. Factors affecting eHAT and its outcomes were examined. Nine patients (5.1%) developed eHAT. In multivariate analysis, intraoperative hepatic artery revision and Roux-en-Y hepaticojejunostomy biliary reconstruction type were statistically significant (all, P < .05). Thrombectomy and reanastomosis was performed in 5 patients. Two of them were successful. In total, 3 retransplantations were performed and all of those patients are still alive. The factors affecting eHAT are still a matter of debate. Intraoperative hepatic artery anastomosis revision and Roux-en-Y hepaticojejunostomy reconstruction were independent risk factors for development of eHAT. In the present study, the confidence interval of the variables is high, therefore exact determination of the risk factors may not be possible. Early detection and thrombectomy and reanastomosis may be the first treatment of choice to rescue the patient and graft. When it fails, retransplantation must be an alternative. The results of the present study state that at least once a day the vascular anastomosis must be examined by Doppler ultrasonography in the post-transplant first week. It must be repeated when liver enzymes increase. The patients under high risk for eHAT may be followed up closer.

Identifiants

pubmed: 31101192
pii: S0041-1345(18)31836-0
doi: 10.1016/j.transproceed.2019.01.104
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1162-1168

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

K Kutluturk (K)

Inonu University Institute of Liver Transplantation, Malatya, Turkey. Electronic address: kkutluturk@gmail.com.

T T Sahin (TT)

Inonu University Institute of Liver Transplantation, Malatya, Turkey.

S Karakas (S)

Inonu University Institute of Liver Transplantation, Malatya, Turkey.

B Unal (B)

Inonu University Institute of Liver Transplantation, Malatya, Turkey.

H G Gozukara Bag (HG)

Inonu University Faculty of Medicine Department of Biostatistics and Bioinformatics, Malatya, Turkey.

S Akbulut (S)

Inonu University Institute of Liver Transplantation, Malatya, Turkey.

C Aydin (C)

Inonu University Institute of Liver Transplantation, Malatya, Turkey.

S Yilmaz (S)

Inonu University Institute of Liver Transplantation, Malatya, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH